Within the beauty industry, skincare is the second-largest contributor to revenue earned in the space — accounting for 23 percent. Since 2019, Ever/Body has catered to the growing interest in personalized, tech-backed, accessible skincare treatments.
On Thursday, the NYC-based company raked in $55.5 million in its Series C funding raise led by Addition, an existing investor. Additional participants in the round include VC giant Tiger Global, ACME Capital, Fifth Wall Ventures and others.
Ever/Body plans to use its new capital to expand across the East Coast. The company currently has three offices in NYC where consumers receive dermatology services backed by medical experts and fueled by the company’s proprietary technology platform. Through its technology, Ever/Body creates a personalized client journey, from appointment scheduling to pre- and post-treatment care.
Ever/Body aims to provide consumers with a full understanding of the services they receive, alongside prioritizing quick services with less recovery time to fit into consumers’ busy schedules.
The company plans to add six new locations, three in NYC and three in Washington, D.C., by the end of 2022.
“Our goal is to change the industry from the inside out,” Amy Shecter, CEO of Ever/Body, said in a statement. “For our providers, we’ve built a more advanced career path with ongoing education and professional development. For our clients, we’ve coupled this provider expertise with a tech-enabled service experience that supports their beauty and wellness goals. We look forward to bringing this new standard of care to more providers and more clients as we expand.”
